๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intravenous Infusion of Nitric Oxide in Experimental Pulmonary Hypertension: Biotransformation and Haemodynamics

โœ Scribed by F. Pirrone; M. Albertini; S. Mazzola; C. Pastore; M. G. Clement; M. C. Benfatto; G. Aldini; M. Carini

Publisher
Springer Netherlands
Year
2007
Tongue
English
Weight
156 KB
Volume
31
Category
Article
ISSN
0165-7380

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High expression of endothelial nitric ox
High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension
โœ Mason, Nicola A.; Springall, David R.; Burke, Margaret; Pollock, Jennifer; Mikha ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 218 KB ๐Ÿ‘ 2 views

The pathogenesis of pulmonary hypertension (PH) remains poorly understood. Vasoconstriction, although likely to be a major factor in the disease, varies between patients and studies of a variety of vasoactive substances have sometimes yielded conflicting results. Amongst these substances, alteration

Inhaled nitric oxide, oxygen, and alkalo
Inhaled nitric oxide, oxygen, and alkalosis: Dose-response interactions in a lamb model of pulmonary hypertension
โœ R. Scott Heidersbach; Michael J. Johengen; Janine M. Bekker; Jeffrey R. Fineman ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

Inhaled nitric oxide (NO) is currently used as an adjuvant therapy for a variety of pulmonary hypertensive disorders. In both animal and human studies, inhaled NO induces selective, dose-dependent pulmonary vasodilation. However, its potential interactions with other simultaneously used pulmonary va

Hemodynamic effects of inhaled nitric ox
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension
โœ De Wolf, A M ;Scott, V ;Bjerke, R ;Kang, Y ;Kramer, D ;Miro, A ;Fung, J J ;Dodso ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 71 KB

Patients with moderate and severe pulmonary hypertension have a very high mortality rate when undergoing orthotopic liver transplantation. Because nitric oxide has been successful in reducing pulmonary artery pressures in certain patients with pulmonary hypertension, the efficacy of NO inhalation (4